Dario Altamirano, DO
Family Medicine · Hialeah, FLNPI 1871571471
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,365 of the $4,233 with a category attached, or 79.5%. 14 manufacturers reported payments, led by Modernatx, Inc. at 27.7% of the total. Reporting peaked in 2024 at $2,307 and has fallen 74.1% since, to $597 in 2025.
Across 97 payments — averaging $43.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$1K
- Amgen$1K
- AstraZeneca$445
- Lilly USA, LLC$424
- Johnson & Johnson$291
- Novo Nordisk$152
- plus $707 from 8 others
Across 922 payments — averaging $16,864 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$11.5M
- H. Lundbeck A S$1.3M
- Modernatx, Inc.$1.1M
- AbbVie$736K
- Ipsen Innovation$479K
- Mitsubishi Tanabe Pharma Development America, Inc.$211K
- plus $224K from 9 others
What the payments were for
- Travel & lodging$86821%
- Food & beverage$3,36579%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 8 | $1,174 |
| Amgen | 31 | $1,038 |
| AstraZeneca | 6 | $445 |
| Lilly USA, LLC | 21 | $424 |
| Johnson & Johnson | 5 | $291 |
| Novo Nordisk | 7 | $152 |
| Boehringer Ingelheim | 2 | $145 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $138 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 1 | $118 |
| Madrigal Pharmaceuticals | 1 | $99 |
| Regeneron | 1 | $94 |
| Exact Sciences | 4 | $80 |
| IBSA Pharma Inc. | 1 | $17 |
| BD | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,233 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $10,489 |
| EliquisApixaban | 11 | $7,874 |
| Ezetimibe | 13 | $799 |
| Atorvastatin Calcium | 57 | $781 |
| Famotidine | 42 | $617 |
| Nifedipine ErNifedipine | 12 | $527 |
| Baclofen | 16 | $313 |
| Glipizide | 12 | $266 |
| Metoprolol Succinate | 13 | $259 |
| Lisinopril | 21 | $170 |
| Metformin Hcl | 24 | $156 |
| Tamsulosin Hcl | 11 | $156 |
| Losartan Potassium | 26 | $151 |
| Levothyroxine Sodium | 17 | $133 |
| Gabapentin | 15 | $119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $145 | $10,48912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Hialeah
- Ivan RodriguezHialeah$41K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.